PFKP and neoplasm: In terms of therapy, these insights suggest that targeting metabolic pathways, such as inhibiting LDHA or PFKP to disrupt glycolysis, or using MTORC1 inhibitors like rapamycin, may alleviate tumor growth and invasion [43].